Back to Search Start Over

Clearance sought for Tremfya for Crohn's disease

Source :
Chain Drug Review. July 15, 2024, Vol. 46 Issue 9, p35, 1 p.
Publication Year :
2024

Abstract

SPRING HOUSE, Pa. -- Johnson & Johnson has submitted a supplemental Biologics License Application (sBLA) to the Food and Drug Administration for Tremfya (guselkumab) for the treatment of adults with [...]

Details

Language :
English
ISSN :
01649914
Volume :
46
Issue :
9
Database :
Gale General OneFile
Journal :
Chain Drug Review
Publication Type :
Periodical
Accession number :
edsgcl.801412043